Read Full Article
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen ...
Karen is a world class cancer researcher and a highly accomplished leader in her field.
Karen brings to the Board deep scientific expertise developed through a successful career in research, including her current leadership role at one of the world's most influential cancer research organizations.
Bristol-Myers Squibb has been at the forefront of researching and developing new therapies that harness the immune system to fight cancer.